findmyKOL
Clinical trialNCT06593847CompletedInterventional

Multisite Virtual Reality Intervention for Speech Anxiety

SponsorBoston University Charles River CampusEnrollment1,542Public SpeakingSpeech Anxiety
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Exposure-based cognitive behavior therapy is an efficacious treatment for speech anxiety and has been delivered effectively in a virtual reality (VR) environment. The present multicenter study (conducted through the Exposure Therapy Consortium) is designed to evaluate whether trait versus state positive affectivity is a more effective predictor of exposure therapy outcomes. Further, the investigators will examine whether the predictive significance of trait positive affectivity can be accounted for by examination of baseline levels of self-efficacy, hope, and optimism.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Western Sydney University

    Penrith, New South Wales, Australia

  • University of New South Wales

    Sydney, New South Wales, Australia

  • Curtin University

    Bently, Western Australia, Australia

China
  • University of Hong Kong

    Pokfulam, Hong Kong, China

Germany
  • Philipps-Universität Marburg

    Marburg, Hesse, Germany

Netherlands
  • Erasmus University

    Rotterdam, South Holland, Netherlands

  • Utrecht University

    Utrecht, Netherlands

United States
  • University of Arizona

    Tucson, Arizona, United States

  • Southern Illinois University

    Carbondale, Illinois, United States

  • Boston University

    Boston, Massachusetts, United States

  • Tufts University

    Boston, Massachusetts, United States

  • Albright College

    Reading, Pennsylvania, United States

  • University of Texas at Austin

    Austin, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
8 Oct 2024
Primary completion
23 Jul 2025
Completion
23 Jul 2025
Last update posted
18 Dec 2025
Registered enrollment
1,542
Registry id
NCT06593847

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.